| Aug 7 |
Editas: Q2 Earnings Snapshot
|
| Aug 7 |
Editas Medicine GAAP EPS of -$0.82 misses by $0.13, revenue of $0.51M misses by $3.63M
|
| Aug 7 |
Editas Medicine Announces Second Quarter 2024 Results and Business Updates
|
| Aug 6 |
Editas Medicine Q2 2024 Earnings Preview
|
| Jul 31 |
Editas Medicine Announces Second Quarter 2024 Results Conference Call and Corporate Update
|
| Jul 17 |
3 Gene-Editing Stocks That Could Be Multibaggers in the Making: July Edition
|
| Jul 9 |
3 Profitable CRISPR Stocks Earning Analysts’ Praise
|
| Jul 8 |
The 3 Best Gene Editing Stocks to Buy in July 2024
|
| Jul 5 |
Editas Medicine (NASDAQ:EDIT) investors are sitting on a loss of 90% if they invested three years ago
|
| Jun 30 |
Is Editas Medicine, Inc. (EDIT) One of the Best Biotech Penny Stocks to Buy Now?
|
